Skip to main content

Romano Kathryn's Form 4 filing

Krystal Biotech, Inc. (KRYS) · filed May 23, 2023

Accession no.
0001801385-23-000004
Filed
May 23, 2023
Trade date
May 19-22, 2023
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 17 non-derivative transactions and 4 derivative transactions. Open-market sales total $5.43M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Romano KathrynCIK 0001801385Officer (Chief Accounting Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 19, 2023Common StockMOption exerciseAcquired+12,500$52.26+$653,25028,484Direct
May 19, 2023Common StockSSaleDisposed−12,500$95.05F2−$1,188,12515,984Direct
May 19, 2023Common StockMOption exerciseAcquired+12,500$52.26+$653,25028,484Direct
May 19, 2023Common StockSSaleDisposed−12,500$95.04F2−$1,188,00015,984Direct
May 19, 2023Common StockSSaleDisposed−3,428$95.08F2−$325,934.2412,556Direct
May 22, 2023Common StockMOption exerciseAcquired+2,521$52.26+$131,747.4615,077Direct
May 22, 2023Common StockSSaleDisposed−2,521$105.80F5−$266,721.812,556Direct
May 22, 2023Common StockMOption exerciseAcquired+2,570$52.26+$134,308.215,126Direct
May 22, 2023Common StockSSaleDisposed−2,570$106.81F6−$274,501.712,556Direct
May 22, 2023Common StockMOption exerciseAcquired+1,300$52.26+$67,93813,856Direct
May 22, 2023Common StockSSaleDisposed−1,300$107.88F7−$140,24412,556Direct
May 22, 2023Common StockMOption exerciseAcquired+2,955$52.26+$154,428.315,511Direct
May 22, 2023Common StockSSaleDisposed−2,955$109.17F8−$322,597.3512,556Direct
May 22, 2023Common StockMOption exerciseAcquired+3,154$52.26+$164,828.0415,710Direct
May 22, 2023Common StockSSaleDisposed−3,154$109.99F9−$346,908.4612,556Direct
May 22, 2023Common StockMOption exerciseAcquired+12,500$63.55+$794,37525,056Direct
May 22, 2023Common StockSSaleDisposed−12,500$110.00F11−$1,375,00012,556Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 19, 2023Common StockMOption exerciseDisposed−12,500$0.00$037,500Direct
May 19, 2023Common StockMOption exerciseDisposed−12,500$0.00$025,000Direct
May 22, 2023Common StockMOption exerciseDisposed−12,500$0.00$012,500Direct
May 22, 2023Common StockMOption exerciseDisposed−12,500$0.00$037,500Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The transaction was executed in multiple trades ranging from $95.0000 to $95.3800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 3 transactions in Table I.

F5

The transaction was executed in multiple trades ranging from $105.3400 to $106.3100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F6

The transaction was executed in multiple trades ranging from $106.3700 to $107.0300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F7

The transaction was executed in multiple trades ranging from $107.6900 to $108.4200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F8

The transaction was executed in multiple trades ranging from $108.9000 to $109.5500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F9

The transaction was executed in multiple trades ranging from $109.9700 to $110.0000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F11

The transaction was executed in a single trade.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)